VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) is scheduled to present at the 28th Annual ROTH Conference on Tuesday, March 15th, 2016 at 5:30 PM PT (8:30 PM ET). The event is being held at the Ritz Carlton in Dana Point, CA.

During the presentation, Jeff Baxter, VBI’s President and CEO, will provide an overview of VBI and its platform technologies, and will summarize recent developments in the company’s pipeline of vaccine candidates. Mr. Baxter will also discuss VBI’s planned merger with SciVac Therapeutics (TSX:VAC and OTCQX:SVACF) (“SciVac”). SciVac’s flagship product, Sci-B-Vac®, is a commercial hepatitis B vaccine.For additional information, or to schedule a one-on-one meeting with VBI management, please contact ir@vbivaccines.com.

Event Details

  • Event: 28th Annual ROTH Conference
  • Date: Tuesday, March 15th, 2016
  • Time: 5:30 PM PT (8:30 PM ET)
  • Location: The Ritz Carlton in Dana Point, CA
  • Event Website: http://bit.ly/roth-2016

 

SUBSCRIBE TO RECEIVE IMPORTANT NEWS AND INSIGHTS BY EMAIL